Mitochondrial dysfunction during sepsis, impact and possible regulating role of hypoxia-inducible factor -1α;Disfunción mitocondrial en sepsis, impacto y posible papel regulador del factor inducible por hipoxia (HIF-1α)

Medicina Intensiva

Volumn 33, Issue 8, 2009, Pages 385-392

  Regueira, T ^a   Andresen, M ^a   Djafarzadeh, S ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Hypoxia inducible factor 1 ; Mitochondrial; Multiorgan dysfunction; Sepsis

Indexed keywords

CITRIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ACIDOSIS; APOPTOSIS; CELL DEATH; CELL ENERGY; CITRIC ACID CYCLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; ENERGY METABOLISM; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HYPOXIA; INFLAMMATION; LYMPHOCYTE FUNCTION; MEMBRANE DAMAGE; MITOCHONDRION; MORTALITY; MULTIPLE ORGAN FAILURE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; OXYGEN TRANSPORT; PATHOPHYSIOLOGY; SEPSIS; SHORT SURVEY;

HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOCHONDRIA; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 70349965990     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2008.10.002     Document Type: Short Survey

References (42)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
2. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 34 (2006) 344-353
3. Elbers P.W., and Ince C. Mechanisms of critical illness--classifying microcirculatory flow abnormalities in distributive shock. Crit Care 10 (2006) 221
4. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutiérrez V., Comstock K.L., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98 (1996) 2854-2865
5. Abraham E. Neutrophils and acute lung injury. Crit Care Med 31 (2003) S195-S199
6. Gattinoni L., Brazzi L., Pelosi P., Latini R., Tognoni G., Pesenti A., et al., SvO2 Collaborative Group. Atrial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333 (1995) 1025-1032
7. Hayes M.A., Timmins A.C., Yau E.H., Palazzo M., Hinds C.J., and Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330 (1994) 1717-1722
8. Hotchkiss R.S., Swanson P.E., Freeman B.D., Tinsley K.W., Cobb J.P., Matuschak G.M., et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27 (1999) 1230-1251
9. Kantrow S.P., Taylor D.E., Carraway M.S., and Piantadosi C.A. Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch Biochem Biophys 345 (1997) 278-288
10. VanderMeer T.J., Wang H., and Fink M.P. Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 23 (1995) 1217-1226
11. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
12. Porta F., Takala J., Weikert C., Bracht H., Kolarova A., Lauterburg B.H., et al. Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function. Crit Care 10 (2006) R118
13. Crouser E.D., Julian M.W., Huff J.E., Struck J., and Cook C.H. Carbamoyl phosphate synthase-1: A marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med 34 (2006) 2439-2446
14. Brealey D., Karyampudi S., Jacques T.S., Novelli M., Stidwill R., Taylor V., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286 (2004) R491-R497
15. Crouser E.D., Julián M.W., Blaho D.V., and Pfeiffer D.R. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 30 (2002) 276-284
16. Kozlov A., Staniek K., Haindl S., Piskernik C., Ohlinger W., Gille L., et al. Different effects of endotoxic shock on the respiratory function of liver and heart mitochondria in rats. Am J Physiol Gastrointest Liver Physiol 290 (2006) 543-549
17. Rosser D.M., Stidwill R.P., Jacobson D., and Singer M. Oxygen tension in the bladder epithelium rises in both high and low cardiac output endotoxemic sepsis. J Appl Physiol 79 (1995) 1878-1882
18. Unno N., Wang H., Menconi M.J., Tytgat S.H., Larkin V., Smith M., et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 113 (1997) 1246-1257
19. Zingarelli B., Day B.J., Crapo J.D., Salzman A.L., and Szabo C. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 120 (1997) 259-267
20. Vary T.C. Increased pyruvate dehydrogenase kinase activity in response to sepsis. Am J Physiol 260 (1991) E669-E674
21. Vary T.C., Siegel J.H., Nakatani T., Sato T., and Aoyama H. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 250 (1986) E634-E640
22. Alamdari N., Constantin-Teodosiu D., Murton A.J., Gardiner S.M., Bennett T., Layfield R., et al. Temporal changes in the involvement of pyruvate dehydrogenase complex in muscle lactate accumulation during lipopolysaccharide infusion in rats. J Physiol 586 (2008) 1767-1775
23. Radi R., Cassina A., and Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 383 (2002) 401-409
24. Radi R., Rodríguez M., Castro L., and Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308 (1994) 89-95
25. Bateman R.M., Tokunaga C., Kareco T., Dorscheid D.R., and Walley K.R. Myocardial hypoxia-inducible HIF-1alpha, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia. Am J Physiol Heart Circ Physiol 293 (2007) H448-H456
26. Szabo C. Poly (ADP-ribose) polymerase activation and circulatory shock. Novartis Found Symp 280 (2007) 92-103 discussion 03-7, 60-4
27. Goldfarb R.D., Marton A., Szabo E., Virag L., Salzman A.L., Glock D., et al. Protective effect of a novel, potent inhibitor of poly (adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 30 (2002) 974-980
28. Semenza G.L. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405 (2007) 1-9
29. 2 sensing. Science 292 (2001) 464-468
30. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002) 858-861
31. Mansfield K.D., Guzy R.D., Pan Y., Young R.M., Cash T.P., Schumacker P.T., et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1 (2005) 393-399
32. Brun-Buisson C., Doyon F., Carlet J., Dellamonica P., Gouin F., Lepoutre A., et al., French ICU Group for Severe Sepsis. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 274 (1995) 968-974
33. Schumacker P.T. Hypoxia-inducible factor-1 (HIF-1). Crit Care Med 33 (2005) S423-S425
34. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 (2003) 645-657
35. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3 (2006) 177-185
36. Fukuda R., Zhang H., Kim J.W., Shimoda L., Dang C.V., and Semenza G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129 (2007) 111-122
37. Blouin C.C., Page E.L., Soucy G.M., and Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1alpha. Blood 103 (2004) 1124-1130
38. Frede S., Stockmann C., Freitag P., and Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J 396 (2006) 517-527
39. Kim H.Y., Kim Y.H., Nam B.H., Kong H.J., Kim H.H., Kim Y.J., et al. HIF-1alpha expression in response to lipopolysaccharide mediates induction of hepatic inflammatory cytokine TNF alpha. Exp Cell Res 313 (2007) 1866-1876
40. Peyssonnaux C., Cejudo-Martín P., Doedens A., Zinkernagel A.S., Johnson R.S., and Nizet V. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 178 (2007) 7516-7519
41. Lukashev D., Klebanov B., Kojima H., Grinberg A., Ohta A., Berenfeld L., et al. Cutting edge: Hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol 177 (2006) 4962-4965
42. Thiel M., Caldwell C.C., Kreth S., Kuboki S., Chen P., Smith P., et al. Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2 (2007) e853